An article published Monday in The Wall Street Journal pointed out that in the likely case that a vaccine candidate is granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA), it won't be covered by Medicare. This is because the massive aid program does not cover the costs of products with EUAs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,